Author Accountability in Biomedical Research

Scientific authorship: a primer for researchers

The International Committee of Medical Journal Editors (ICMJE) proposed the authorship criteria which can be employed by medics and allied specialists. Scholars who substantively contribute to research and writing, revise, approve final drafts for target journal submissions, and take responsibility for all aspects of the work deserve authorship. Increasing awareness of the ICMJE criteria, incorporating related points in journal instructions, and enforcing them in daily practice may have positive impact for healthcare. Instances of inappropriate authorship are ethical transgressions which can be avoided by editors employing strategies of author profile evaluations. There are several platforms for recording author accomplishments which may improve the discoverability of scholarly works and prevent unethical conduct.

Most publishers advise authors to submit their Open Researcher and Contributor IDs (ORCID) at the manuscript submission. Other identifiers, such as Twitter handles, are also emerging as tools to stimulate post-publication communication and increase authors’ accountability for published articles.

Stromal vascular fraction technologies and clinical applications

Introduction: The heterogeneous pool of cells found in the stromal vascular fraction of adipose tissue (SVF) and the purified mesenchymal stromal/stem cells (ASCs) isolated from this pool have increasingly been used as therapeutic tools in regenerative medicine.Areas covered: As SVF and ASCs are different, and should be used in different manners according to various clinical and biological indications, we reviewed the current literature, and focused on the clinical use of SVF to appraise the main medical fields for development. Both enzymatic digestion and mechanical disruption have been used to obtain SVF for non-homologous use. The safety and/or benefits of SVF have been examined in 71 clinical studies in various contexts, mainly musculoskeletal conditions, wound healing, urogenital, and cardiovascular and respiratory diseases. The use of SVF as a therapy remains experimental, with few clinical trials.Expert opinion: SVF provides a cellular and molecular microenvironment for regulation of ASC' activities under different clinical conditions. SVF may enhance angiogenesis and neovascularization in wound healing, urogenital and cardiovascular diseases. In joint conditions, therapeutic benefits may rely on paracrine immune-modulatory and anti-inflammatory mechanisms. Novel point of care methods are emerging to refine SVF in ways that meet the regulatory requirements for minimal manipulation.